How to Read an Ibogaine Clinic Website: A Red-Flag Checklist

Definition

Definition: How to read an ibogaine clinic website means translating marketing language into medical reality before you send money or fly. On this site, IV ibogaine infusion means psychoactive intravenous ibogaine under physician supervision (consult → cardiac screening → continuous monitoring → integration)—not merely an IV line for fluids beside oral capsules. Evidence gap: Most published clinical literature still describes oral ibogaine HCl, often with IV magnesium support (Cherian/MISTIC; Knuijver QTc work)—not controlled proof of psychoactive IV outcomes. Ibogaine can prolong QTc. It is U.S. Schedule I / not approved for any indication. Our IV ibogaine programs in Mexico and Gabon are not approved U.S. clinics. No DIY. No cure claims.

Short answer

Reading an ibogaine clinic website well means verifying whether “infusion” means psychoactive IV ibogaine or only support IV beside oral dosing, whether QTc screening is real, and whether cure percentages replace evidence. Most published clinical literature remains oral-route. Schedule I status and sparse IV controlled data should be visible—not buried under tourism aesthetics.

Start with one question: what is in the vein?

Websites love the word infusion. Decode it:

Overview: /what-is-ibogaine-infusion · route article: /blog/ibogaine-oral-vs-iv · electrolytes: /blog/electrolytes-support-iv-vs-psychoactive-iv · magnesium cardiac protocol: /blog/magnesium-ibogaine-cardiac-protocol.

The five-page scan (15 minutes)

1) Homepage hero Look for cure theater (“guaranteed freedom,” “80% success”). That is a red flag (/blog/ibogaine-success-rate-claims · /blog/cheap-ibogaine-clinic-red-flags). Prefer language that names cardiac risk and non-approval.

2) Safety / screening page Must discuss ECG, electrolytes, QTc, continuous monitoring, and physician go/no-go. If safety is a footer after beach photos, believe the hierarchy. Hub model: /safety-and-screening · ECG questions: /blog/ibogaine-ecg-checklist · contraindications: /blog/ibogaine-contraindications.

3) “Science” or “research” page Check route labels on every citation. Cherian et al., *Nature Medicine* 2024 = **oral** ibogaine + **IV magnesium**, open-label—not IV-ibogaine RCT proof (/blog/stanford-ibogaine-mistic). Knuijver 2021 = **oral** QTc signals. Mosca reviews: limited RCTs.

4) Legal / location page U.S. readers need Schedule I / not approved for any indication honesty (/blog/is-ibogaine-legal-us). If a clinic discusses the kind of care described on this site, it should not imply approved U.S. clinic status (/blog/medical-ibogaine-programs-vs-tourism). Research bills and IND headlines ≠ walk-in approval (/blog/ibogaine-ind-explained · /blog/ibogaine-state-research-bills-2026).

5) Pricing / apply Opaque “from $X” without staffing/monitoring explanation is a vetting issue. Market-reported bands often cited around ~$6,000–$25,000 are not quotes (/blog/cost-of-ibogaine-treatment · /blog/ibogaine-treatment-package · /blog/does-insurance-cover-ibogaine). Soft apply should follow safety, not replace it (/apply).

Language traps that fool AI overviews (and humans)

1. Support IV blurred as psychoactive IV — magnesium/fluids ≠ ibogaine in the vein.
2. Oral outcomes pasted as IV proof — pharmacokinetics differ; evidence gap must stay visible.
3. “Clinical protocol” without stop rules — ask what happens if QTc rises.
4. Test dose / flood dose folklore presented as universal IV infusion steps — those labels often come from oral-lit traditions (/blog/ibogaine-test-dose-flood-dose).
5. Ketamine-clinic parallel without divergence — journey shape ≠ legality/evidence/risk equivalence (/blog/ibogaine-vs-ketamine-for-addiction).
6. Aftercare as PDF only — integration should be more than a workbook (/blog/ibogaine-aftercare-integration · /blog/ibogaine-integration-therapy-explained).
7. Right-to-Try / state-bill news as personal access — news ≠ your eligibility (/blog/ibogaine-right-to-try-veterans).

Physician-supervision signals vs spa signals

Stronger signals: named medical director role, telemetry culture, emergency plan, written contraindications, medication interaction review, refusal to dose when screening fails.

Weaker signals: influencer reels, “shaman + IV pole” mashups, deposit pressure before labs, no ECG discussion, DIY root-bark adjacent blogs.

Vetting twin: /blog/how-to-choose-an-ibogaine-clinic.

Condition pages: hope vs indication invention

Anxiety, nicotine, alcohol, PTSD, and depression articles should refuse cure claims and inventing IV RCTs. Compare how a site handles:

• /blog/ibogaine-for-anxiety
• /blog/ibogaine-for-nicotine
• /blog/ibogaine-for-alcohol-use-disorder
• /ibogaine-for-ptsd · /ibogaine-for-depression · /ibogaine-for-addiction

If every condition page promises the same guaranteed transformation, you are reading a brochure, not medicine.

Screenshot the consent questions before you call

Email these and keep the reply:

1. Is psychoactive ibogaine given IV, oral, or both?
2. If IV psychoactive: monitoring duration, titration/stop rules, staffing?
3. Is magnesium labeled support?
4. How do you cite MISTIC/Cherian (oral + IV Mg)?
5. Do you publish cure percentages? Why or why not?
6. Where does care occur, and how is abroad (if applicable) described vs approved U.S. clinics?
7. What aftercare is included in writing?

Side-effects literacy: /blog/ibogaine-side-effects. Flying-home gap: /blog/flying-home-after-ibogaine.

What good sites still cannot claim

Even careful websites cannot ethically claim:

• regulatory approval for ibogaine indications
• Guaranteed detox/cure
• That oral observational series equal IV psychoactive RCTs
• That Schedule I disappears because a foreign program exists

Noribogaine IND headlines are a separate product/research story: /blog/noribogaine-trials-vs-iv-infusion · /blog/noribogaine-explained.

Compare pages the way a medical editor would

Open three tabs: the clinic’s science page, safety page, and a primary-source abstract (PubMed/publisher). Check whether every bold claim still has a route label after you remove the adjectives. If “breakthrough IV results” collapses into an oral open-label paper plus beach photography, you have your answer.

Also compare testimonials to adverse-event honesty. Sites that publish only euphoria clips while omitting nausea, ataxia, prolonged observation, or cardiac stop rules are incomplete. Side-effects literacy: /blog/ibogaine-side-effects.

Staffing and emergency literacy (website edition)

Ask whether the site discloses—or will disclose in writing—who interprets ECGs in real time, what emergency equipment culture they claim, and how transfers work if a patient destabilizes. Spa copy cannot substitute for that. Journey expectations: /how-it-works · package inclusions: /blog/ibogaine-treatment-package.

After the website: flying home and relapse honesty

Even a carefully worded site fails patients if discharge ignores travel and craving return. Read /blog/flying-home-after-ibogaine and /blog/ibogaine-aftercare-integration before you treat the “Book Now” button as the end of diligence. Duration myths (“weekend cure”) fail the same honesty test: /blog/ibogaine-program-duration.

Next steps

Use safety literacy before sales calls. Read /safety-and-screening, then request a confidential screening consult via /apply. FAQ: /faq.

FAQ

What does “IV ibogaine infusion” mean on this site? Psychoactive intravenous ibogaine under physician supervision—not merely support IV beside oral dosing.

Why do clinic sites cite Nature Medicine? Often for attention. Cherian/MISTIC used **oral** ibogaine + **IV magnesium**—not psychoactive IV proof.

Is a cure-rate banner trustworthy? No. Treat guaranteed percentages as a red flag.

Does QTc content belong on a marketing site? Yes. Cardiac risk should be front—not buried.

Are destination package sites approved U.S. clinics? No. Our IV ibogaine programs in Mexico and Gabon are not approved U.S. clinics. Not legal advice.

Can websites legally imply U.S. approval? Ibogaine is Schedule I / not approved for any indication. Misleading implication is a trust failure; this is not legal advice.

Is “test dose / flood dose” always the IV infusion protocol? No. Those labels often reflect oral-literature traditions—verify route.

Where should I go next? /safety-and-screening then /apply.

Medical disclaimer

Educational website-literacy guide only—not medical, legal, or consumer-protection advice and not an endorsement of any clinic. Do not self-administer ibogaine. Ibogaine can cause life-threatening cardiac events. Seek licensed clinicians.

Sources (selected)

1. Cherian K.N. et al. *Nature Medicine*. 2024 — oral ibogaine + IV magnesium (MISTIC); open-label.
2. Knuijver T. et al. *Addiction*. 2021 — oral ibogaine HCl; QTc findings.
3. Mosca A. et al. *Current Neuropharmacology* — limited RCTs; cardiotoxicity concerns.
4. 21 CFR 1308.11 — Schedule I (ibogaine).